PROFUSA, INC. Temporary Equity, Other Changes
PROFUSA, INC. (PFSA) reported Temporary Equity, Other Changes of $10.62 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued
us-gaap:TemporaryEquityOtherChanges · last filed 2023-11-20
- PROFUSA, INC. temporary equity, other changes for the quarter ending 2023-09-30 was $242.05K.
- PROFUSA, INC. temporary equity, other changes for the quarter ending 2023-06-30 was $419.67K.
- PROFUSA, INC. temporary equity, other changes for the quarter ending 2023-03-31 was $9.96M.
| Period end | Temporary Equity, Other Changes 3 month | Temporary Equity, Other Changes 6 month | Temporary Equity, Other Changes 9 month | Temporary Equity, Other Changes 12 month |
|---|---|---|---|---|
| 2023-09-30 | $242.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $661.72K derived: sum of 2 quarters · filed 2023-11-20 | $10.62M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $419.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $10.38M 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $9.96M 10-Q · filed 2023-05-17 | |||
| 2022-12-31 | $193.53M 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |